期刊文献+

瑞芬太尼与氯胺酮用于剖宫产全麻时对血压、心率及胎儿评分影响的比较 被引量:16

Effects of Remifentanly and Ketamin on Parturient Blood Pressure,Heart Rate and Neonate Apgar Score
原文传递
导出
摘要 目的:对照研究在全麻剖宫产术中应用瑞芬太尼和氯胺酮诱导对母婴的影响。方法:选择100例禁忌椎管内麻醉而须行全麻剖宫产手术的患者,分为两组,氯胺酮组静注异丙酚1.5 mg/kg+氯胺酮1 mg/kg+琥珀胆碱1.5 mg/kg;瑞芬太尼组静注异丙酚1.5 mg/kg+瑞芬太尼1μg/kg+琥珀胆碱1.5 mg/kg诱导插管,胎儿娩出后均静注芬太尼2 g/kg、泵注异丙酚3 mg/(kg.h)和吸入异氟醚0.5MAC维持麻醉,阿曲库铵维持肌松。结果:瑞芬太尼组插管(切皮)后血压、心率升高幅度显著小于氯胺酮组,两组新生儿1 min、5 min Apgar评分无明显差异。结论:瑞芬太尼用于产科全麻优于氯胺酮,安全可行。 Objective:To compare the effects of remifentanyl with ketamin on parturients and neonates used in general aneasthesia in cesarean resections.Methods:One hundred parturients contraindicated intraspinal anaesthesia undergoing cesarean resection were divided into two groups.In group Ⅰ anaesthesia was induced with propofol 1.5 mg/kg+ketamin 1 mg/kg+scolin 1.5 mg/kg and group Ⅱ with propofol 1.5 mg/kg+remifentanyl 1.51 μg/kg +scolin 1.5 mg/kg.Anaesthesia were maintained with fentanly,propofol,atracurium and inhalation of 0.5MAC sevofluren in both groups. Results: Increases of blood pressure and heart rate were significantly lower in group Ⅱ than in group Ⅰ (P〈0.05). There was no significant difference of 1 min and 5 min Apgar scores of neonate between two groups. Conclusion: Remifentanyl is better than ketanmine and can be safely used in general aneasthesia in ceasarin resections.
出处 《华西医学》 CAS 2009年第8期2114-2116,共3页 West China Medical Journal
关键词 全身麻醉 剖宫产 瑞芬太尼 氯胺酮 APGAR评分 general aneasthesia cesarean resections remifentanyl ketamin Apgar score
  • 相关文献

参考文献6

二级参考文献34

  • 1Glass PS, Gan TJ, Howell S .A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999,89: S7-S14.
  • 2James MK. Remifentanil and anesthesia for the future. Exp Opin Invest Drugs 1994,3:331-340.
  • 3Guy J, Hindman BJ, Baker KZ, et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial spaceoccupying lesions. Anesthesiology, 1997,86:514-524.
  • 4Unlugenc H, Itegin M, Ocal I, et al. Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips. Acta Anaesthesiol Scand,2003, 47:65-69.
  • 5Noseir RK, Ficke DJ, Kundu A, et al .Sympathetic and vascular consequences from remifentanil in humans. Anesth Analg, 2003, 96:1645-1650.
  • 6Twersky RS, Jameson B, Warner DS, et al. Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth, 2001,13:407-416.
  • 7Howie MB, Cheng D, Newman MF, et al. A randomized double- blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. Anesth Analg,1996,82:S151.
  • 8Dershwitz M,Randel GI,Rosow CE,et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg, 1995,81:619-623.
  • 9Davis PJ, Ross AK, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age. Anesth Analg, 1995,80:S93.
  • 10Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting,mu-opioid. Anesth Analg, 1996,83: 646-651.

共引文献628

同被引文献111

引证文献16

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部